DarioHealth (DRIO)
Combines connected devices, software, and coaching for chronic-condition care.
Something off on this page? Send us feedback.
Provides digital care for cardiometabolic and behavioral-health needs through connected devices, software, coaching, and support. Employers and health plans primarily offer the services to eligible members through a B2B2C model; the company reports one operating segment.
Combines digital engagement, connected devices, condition monitoring, coaching, communications, analytics, alerts, and support for cardiometabolic and behavioral-health needs. Its deployed solutions cover diabetes, hypertension, pre-diabetes, musculoskeletal care, and behavioral health. The offering expanded from diabetes support into a multi-condition platform.
Revenue primarily comes through B2B2C arrangements: employers, health plans, and other enterprise customers offer the services to eligible members. Providers and pharmaceutical companies are also customers, while retained direct-to-consumer activity in the United States and selected international markets tests features before enterprise deployment. Acquisitions, including Twill, expanded the platform’s digital-led-care capabilities. The company reports one operating segment.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Nov 14, 2025 | Stifel Nicolaus | Target | Target: — | Target: $16 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $14.3M · Total debt $32.4M · Total assets $96.6M · Shareholders' equity $55.1M
- Revenue
- $5.2M
- Operating income
- −$6.5M
- Net income
- −$7.9M
No dividends on record.
| Institutions | 11.72% | 856.8K shares | |
|---|---|---|---|
| 22 holders · as of Jun 30, 2026 | |||
| Insiders | 6.13% | 448.3K shares | |
| 13 holders · as of Jul 28, 2026 | |||
| Strategic holders | 19.21% | 1.40M shares | |
| 4 holders · as of Dec 16, 2025 | |||
| Other | 62.94% | 4.60M shares | |
| remainder | |||
7.31M company shares as of Aug 29, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (9.80M in the company's Sep 23, 2026 report, 7.31M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Tasso Partners, LLCStrategic | 9.25% | 676,141 | filed Nov 12, 2025 |
Craig Kallman 2015 Living TrustStrategic | 9.23% | 675,165 | filed Dec 16, 2025 |
Nantahala Capital Management, LLCInstitution | 8.35% | 610,691 | as of Jun 30, 2026 |
Erez Raphael1Insiderdirector, officer: Chief Executive Officer | 1.92% | 4,778 | filed Sep 15, 2025 |
Vanguard Capital Management LLCInstitution | 0.90% | 65,675 | as of Jun 30, 2026 |
- Erez Raphael's own ownership statement (13D, Feb 10, 2017) plus the 135.4K net shares acquired since reports fewer shares than the transaction reports; the statement is used.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 23, 2026 | Dennis Matheis | director | +14,430 | $6.93 |
- Teladoc Health
Integrated virtual care across chronic and behavioral health
- Omada Health
B2B virtual care for cardiometabolic and MSK conditions
- Hims & Hers Health
D2C cardiometabolic and GLP-1 health-platform overlap
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DarioHealth | $6.92 | +0.44% | $50.4M | 10.0 | — | 2.4 | −3.6% |
| Teladoc Health | $6.22 | −2.13% | $1.15B | — | — | 0.5 | −4.0% |
| Omada Health | $20.85 | −2.42% | $1.27B | 339.2 | 70.1 | 4.1 | +43.1% |
| Hims & Hers Health | $29.44 | −3.25% | $6.79B | — | 136.9 | 2.6 | +38.3% |
| Median | 339.2 | 103.5 | 2.6 | +38.3% |